A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Tazarotene
Spirapril
Arsenic trioxide may increase the hypotensive activities of Spirapril.
Tazarotene
Saprisartan
Arsenic trioxide may increase the hypotensive activities of Saprisartan.
Tazarotene
Practolol
Arsenic trioxide may increase the hypotensive activities of Practolol.
Tazarotene
Bevantolol
Arsenic trioxide may increase the hypotensive activities of Bevantolol.
Tazarotene
Rescinnamine
Arsenic trioxide may increase the hypotensive activities of Rescinnamine.
Tazarotene
Trimethaphan
Arsenic trioxide may increase the hypotensive activities of Trimethaphan.
Tazarotene
Pentolinium
Arsenic trioxide may increase the hypotensive activities of Pentolinium.
Tazarotene
Deserpidine
Arsenic trioxide may increase the hypotensive activities of Deserpidine.
Tazarotene
Omapatrilat
Arsenic trioxide may increase the hypotensive activities of Omapatrilat.
Tazarotene
Alprenolol
Arsenic trioxide may increase the hypotensive activities of Alprenolol.
Tazarotene
Tedizolid phosphate
The risk or severity of myelosuppression can be increased when Arsenic trioxide is combined with Tedizolid phosphate.
Tazarotene
Reviparin
The risk or severity of bleeding can be increased when Reviparin is combined with Arsenic trioxide.
Tazarotene
Edetic acid
The risk or severity of bleeding can be increased when Edetic acid is combined with Arsenic trioxide.
Tazarotene
Troxerutin
The risk or severity of bleeding can be increased when Troxerutin is combined with Arsenic trioxide.
Tazarotene
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Arsenic trioxide.
Tazarotene
Vorapaxar
The risk or severity of bleeding can be increased when Vorapaxar is combined with Arsenic trioxide.
Tazarotene
Ticagrelor
The risk or severity of bleeding can be increased when Ticagrelor is combined with Arsenic trioxide.
Tazarotene
Apixaban
The risk or severity of bleeding can be increased when Apixaban is combined with Arsenic trioxide.
Tazarotene
(S)-Warfarin
The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Arsenic trioxide.
Tazarotene
Diphenadione
The risk or severity of bleeding can be increased when Diphenadione is combined with Arsenic trioxide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3